1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > Global In Vitro Fertilization (IVF) Market (Instruments, Reagents and Media, Technology, Geography) - Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research, Report, Company Profiles, Segmentation and Forecast, 2013 - 2020

In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39.  Other driving factors of the IVF market are rise in infertility rate due to rise in stress levels, change in life style and fertility related diseases. Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.The major limiting factor of this market is the cost involved in the treatment. The patient may not conceive in the first cycle of IVF procedure. Many cycles have to be undergone by the patient to achieve pregnancy, and this adds to the overall cost. The average cost of this procedure is approximately $10,000-$20,000. This acts as a major limitation in adoption of the technique for people with low income. Another challenge is the low level of awareness in the developing economies such as Nigeria. Awareness can be created through medical tourism and availability of low cost IVF treatments.The companies profiled in this report include Vitrolife AB, Cooper Surgical. Inc., Cook Medicals, Thermo Scientific, Irvine Scientific Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and Ova Science.

KEY BENEFITS
In-depth analysis of the IVF market, segmented based on instruments, reagents and media, technology, end users and geographiesQuantitative analysis of the current market and estimations through 2013-2020   Assessment and ranking of the factors affecting the global market and impact analysis of the same  Identification of key investment pockets in the market, which would assist companies to take profitable investment decisionsStudy of the bargaining power of buyers and suppliers in the market, based on porter’s five force analysisUnderstanding the key intermediaries in the market based on value chain analysisAnalysis of trends in various geographic segments that would help the companies to plan their strategies depending on the regionSWOT and competitive analysis of the key players, which would help stakeholders to understand trends followed by their competitors and take actionable decisions

KEY AUDIENCES
HospitalsFertility clinicsInstruments and reagent manufacturersCryopreservation banksGovernment and private institutes

Table Of Contents

Global In Vitro Fertilization (IVF) Market (Instruments, Reagents and Media, Technology, Geography) - Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research, Report, Company Profiles, Segmentation and Forecast, 2013 - 2020
CHAPTER 1 INTRODUCTIONandnbsp;1.1 Key Benefitsandnbsp;1.2 Key Audiencesandnbsp;1.3 Research Methodologyandnbsp;andnbsp;andnbsp; 1.3.1 Secondary researchandnbsp;andnbsp;andnbsp; 1.3.2 Primary researchandnbsp;andnbsp;andnbsp; 1.3.3 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARYCHAPTER 3 GLOBAL IVF MARKET OVERVIEWandnbsp;3.1 Market definition and scopeandnbsp;3.2 Alternative technologiesandnbsp;andnbsp;andnbsp; 3.2.1 IUI techniqueandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.1.1 Factors assessed for the procedureandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.1.2 Reasons for use of the techniqueandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.1.3 Benefits of this techniqueandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.1.4 Risksandnbsp;andnbsp;andnbsp; 3.2.2 Difference between IUI and IVF techniqueandnbsp;andnbsp;andnbsp; 3.2.3 GIFT techniqueandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.3.1 Difference between GIFT and IVF techniqueandnbsp;andnbsp;andnbsp; 3.2.4 ZIFT techniqueandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.4.1 Differences between ZIFT and IVF techniqueandnbsp;3.3 Replacing IVF procedures by fertility drugs and surgeriesandnbsp;andnbsp;andnbsp; 3.3.1 Female infertility treatmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.3.1.1 Limitations of fertility drugsandnbsp;andnbsp;andnbsp; 3.3.2 Male infertility treatmentsandnbsp;3.4 Costs related to IVF proceduresandnbsp;3.5 Role of donors in the IVF marketandnbsp;andnbsp;andnbsp; 3.5.1 Egg donationandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.5.1.1 Egg sharingandnbsp;andnbsp;andnbsp; 3.5.2 Sperm donationandnbsp;andnbsp;andnbsp; 3.5.3 Embryo donationandnbsp;andnbsp;andnbsp; 3.5.4 Donation for researchandnbsp;3.6 Surrogacyandnbsp;andnbsp;andnbsp; 3.6.1 Legal issuesandnbsp;3.7 Rise in same sex couplesandnbsp;andnbsp;andnbsp; 3.7.1 Artificial inseminationandnbsp;andnbsp;andnbsp; 3.7.2 Surrogate mothersandnbsp;andnbsp;andnbsp; 3.7.3 In-vitro fertilizationandnbsp;3.8 Advanced technologies in IVFandnbsp;andnbsp;andnbsp; 3.8.1 Capsule IVFandnbsp;andnbsp;andnbsp; 3.8.2 Three parent IVFandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.2.1 Ethical concernsandnbsp;andnbsp;andnbsp; 3.8.3 Mini IVFandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.3.1 Advantagesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.3.2 Drawbacksandnbsp;andnbsp;andnbsp; 3.8.4 EmbryoScopeandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.4.1 Advantagesandnbsp;andnbsp;andnbsp; 3.8.5 PICSIandnbsp;3.9 Fertility treatment and Gender selectionandnbsp;andnbsp;andnbsp; 3.9.1 Methods of sex selectionandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.9.1.1 Gradient methodandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.9.1.2 Flow cytometry techniqueandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.9.1.3 Pre-implantation genetic diagnosis (PGD)andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.9.1.4 Ethical and legal issuesandnbsp;3.10 Metabolomics in embryo screening methodsandnbsp;3.11 Application of stem cells in IVFandnbsp;3.12 IVF and resource poor countriesandnbsp;3.13 Top ten factors impacting IVF marketandnbsp;3.14 Top winning strategies in the IVF marketandnbsp;3.15 Porterandrsquo;s five forces analysisandnbsp;andnbsp;andnbsp;andnbsp; 3.15.1 Competition declining suppliers powerandnbsp;andnbsp;andnbsp;andnbsp; 3.15.2 Availability of options impacting buyer powerandnbsp;andnbsp;andnbsp;andnbsp; 3.15.3 High cost -a hindrance to new entrantsandnbsp;andnbsp;andnbsp;andnbsp; 3.15.4 Application of strategies to overcome competitionandnbsp;andnbsp;andnbsp;andnbsp; 3.15.5 Inefficient threat from substitutesandnbsp;3.16 Value chain analysisandnbsp;3.17 Insurance reimbursement Scenarioandnbsp;3.18 Regulatory issues and legislationsandnbsp;3.19 Clinical trialsandnbsp;andnbsp;andnbsp;andnbsp; 3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVFandnbsp;andnbsp;andnbsp;andnbsp; 3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndromeandnbsp;andnbsp;andnbsp;andnbsp; 3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulationandnbsp;andnbsp;andnbsp;andnbsp; 3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatmentandnbsp;andnbsp;andnbsp;andnbsp; 3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failuresandnbsp;3.20 Market dynamicsandnbsp;andnbsp;andnbsp;andnbsp; 3.20.1 Driversandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.1.1 Ageandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.1.2 Rise in infertility ratesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.1.3 Advancement in technologyandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.1.4 Rise in donationandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.1.5 Increase in average incomeandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.1.6 Increase in success ratesandnbsp;andnbsp;andnbsp;andnbsp; 3.20.2 Restraintsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.2.1 Physical and emotional impactandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.2.2 Ethical and legal issuesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.2.3 Cost of the treatmentandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.2.4 Multiple pregnanciesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.2.5 Low awareness levelandnbsp;andnbsp;andnbsp;andnbsp; 3.20.3 Opportunities:andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.3.1 Medical tourismandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.3.2 New technology trendsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.20.3.3 Rise in same sex marriagesCHAPTER 4 GLOBAL IVF MARKET BY INSTRUMENTSandnbsp;4.1 Global IVF market by instruments types, 2012-2020,$millionandnbsp;4.2 Global IVF instruments market, by geography, 2012-2020, $millionandnbsp;4.3 Incubatorsandnbsp;andnbsp;andnbsp; 4.3.1 Global IVF incubators market , by geography, 2012-2020, $millionandnbsp;4.4 Cryosystemandnbsp;andnbsp;andnbsp; 4.4.1 Global IVF cryosystem market, by geography, 2012-2020, $millionandnbsp;4.5 Imaging systemandnbsp;andnbsp;andnbsp; 4.5.1 Global IVF Imaging system market , by geography, 2012-2020, $millionandnbsp;4.6 Cabinet( work station)andnbsp;andnbsp;andnbsp; 4.6.1 Global IVF cabinets market , by geography, 2012-2020, $millionandnbsp;4.7 Ovum Aspiration pumpandnbsp;andnbsp;andnbsp; 4.7.1 Global IVF ovum aspiration pump market , by geography, 2012-2020, $millionandnbsp;4.8 Sperm separation systemandnbsp;andnbsp;andnbsp; 4.8.1 Global IVF Sperm seperation system market, by geography, 2012-2020, $millionandnbsp;4.9 Accessories and disposablesandnbsp;andnbsp;andnbsp; 4.9.1 Semen analysis chamberandnbsp;andnbsp;andnbsp; 4.9.2 Plastic wareandnbsp;andnbsp;andnbsp; 4.9.3 Oocyte retrieval needlesandnbsp;andnbsp;andnbsp; 4.9.4 Miscellaneous disposablesandnbsp;andnbsp;andnbsp; 4.9.5 Global IVF accessories and disposable market , by geography, 2012-2020, $millionandnbsp;4.10 Micro Manipulator Systemandnbsp;andnbsp;andnbsp;andnbsp; 4.10.1 Global IVF Micromanipulator market , by geography, 2012-2020, $millionandnbsp;4.11 Othersandnbsp;andnbsp;andnbsp;andnbsp; 4.11.1 Refrigeratorsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.11.1.1 Global IVF other instruments market , by geography, 2012-2020, $millionCHAPTER 5 GLOBAL IVF MARKET BY REAGENTS AND MEDIAandnbsp;5.1 Global IVF market by reagents and media types,2012-2020,$millionandnbsp;5.2 Global IVF reagents and media market, by geography, 2012-2020, $millionandnbsp;5.3 Cryopreservation mediaandnbsp;andnbsp;andnbsp; 5.3.1 Embryo cryopreservation mediaandnbsp;andnbsp;andnbsp; 5.3.2 Sperm cryopreservation mediaandnbsp;andnbsp;andnbsp; 5.3.3 Oocyte cryopreservation mediaandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 5.3.3.1 Disadvantageandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 5.3.3.2 Advantagesandnbsp;andnbsp;andnbsp; 5.3.4 Global IVF cryopreservation media market , by geography, 2012-2020, $millionandnbsp;5.4 Semen processing mediaandnbsp;andnbsp;andnbsp; 5.4.1 Global IVF semen processing media market , by geography, 2012-2020, $millionandnbsp;5.5 Ovum processing mediaandnbsp;andnbsp;andnbsp; 5.5.1 Global IVF ovum processing media market , by geography, 2012-2020, $millionandnbsp;5.6 Embryo culture mediaandnbsp;andnbsp;andnbsp; 5.6.1 Global IVF embryo culture media market , by geography, 2012-2020, $millionCHAPTER 6 GLOBAL IVF MARKET BY TECHNOLOGYandnbsp;6.1 Global IVF market, by technology, 2012-2020, $millionandnbsp;6.2 Global IVF technology market, by geography, 2012-2020, $millionandnbsp;6.3 PGD techniqueandnbsp;andnbsp;andnbsp; 6.3.1 Driversandnbsp;andnbsp;andnbsp; 6.3.2 Restraintsandnbsp;andnbsp;andnbsp; 6.3.3 Global IVF pre-implantation genetic diagnosis market , by geography, 2012-2020, $millionandnbsp;6.4 FER techniqueandnbsp;andnbsp;andnbsp; 6.4.1 Reasons to use this techniqueandnbsp;andnbsp;andnbsp; 6.4.2 Advantages of FER techniqueandnbsp;andnbsp;andnbsp; 6.4.3 Disadvantages of FER techniqueandnbsp;andnbsp;andnbsp; 6.4.4 Global IVF Frozen embryo replacement market , by geography, 2012-2020, $millionandnbsp;6.5 ICSI Techniqueandnbsp;andnbsp;andnbsp; 6.5.1 Benefitsandnbsp;andnbsp;andnbsp; 6.5.2 Risksandnbsp;andnbsp;andnbsp; 6.5.3 Global IVF intra cytoplasmic sperm injection market , by geography, 2012-2020, $millionandnbsp;6.6 Others:andnbsp;andnbsp;andnbsp; 6.6.1 Global IVF other technology market , by geography, 2012-2020, $millionandnbsp;andnbsp;andnbsp; 6.6.2 IVM Techniqueandnbsp;andnbsp;andnbsp; 6.6.3 Assisted hatchingCHAPTER 7 GLOBAL IVF MARKET BY END USERSandnbsp;7.1 Global IVF market by end users, 2012-2020, $millionandnbsp;7.2 Global IVF end use market, by geography, 2012-2020, $millionandnbsp;7.3 Hospitalsandnbsp;andnbsp;andnbsp; 7.3.1 Global IVF Hospitals market , by geography, 2012-2020, $millionandnbsp;7.4 Clinicsandnbsp;andnbsp;andnbsp; 7.4.1 Global IVF Clinics market , by geography, 2012-2020, $millionandnbsp;7.5 Surgical centersandnbsp;andnbsp;andnbsp; 7.5.1 Global IVF Surgical centers market , by geography, 2012-2020, $millionandnbsp;7.6 Clinical research institutesandnbsp;andnbsp;andnbsp; 7.6.1 Global IVF clinical research institutes market , by geography, 2012-2020, $millionandnbsp;7.7 Banksandnbsp;andnbsp;andnbsp; 7.7.1 Global IVF banks market , by geography, 2012-2020, $millionCHAPTER 8 IVF MARKET BY GEOGRAPHYandnbsp;8.1 EMEAandnbsp;8.2 North Americaandnbsp;andnbsp;andnbsp; 8.2.1 North American IVF market, 2012-2020, $millionandnbsp;8.3 Asia pacificandnbsp;andnbsp;andnbsp; 8.3.1 Asia Pacific IVF market, 2012-2020, $millionandnbsp;8.4 RoWandnbsp;andnbsp;andnbsp; 8.4.1 RoW IVF market, 2012-2020, $millionCHAPTER 9 COMPANY PROFILESandnbsp;9.1 Vitrolife ABandnbsp;andnbsp;andnbsp; 9.1.1 Company overviewandnbsp;andnbsp;andnbsp; 9.1.2 Company snapshotandnbsp;andnbsp;andnbsp; 9.1.3 Business performanceandnbsp;andnbsp;andnbsp; 9.1.4 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.1.4.1 Primary strategies: regulatory approvals, acquisition and agreementsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.1.4.2 Othersandnbsp;andnbsp;andnbsp; 9.1.5 SWOT Analysis of Vitrolife ABandnbsp;9.2 EMD Serono, Incandnbsp;andnbsp;andnbsp; 9.2.1 Company overviewandnbsp;andnbsp;andnbsp; 9.2.2 Company snapshotandnbsp;andnbsp;andnbsp; 9.2.3 Business performanceandnbsp;andnbsp;andnbsp; 9.2.4 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.2.4.1 Primary strategiesandnbsp;andnbsp;andnbsp; 9.2.5 SWOT Analysis of EMD Serono, Incandnbsp;9.3 Irvine scientificandnbsp;andnbsp;andnbsp; 9.3.1 Company overviewandnbsp;andnbsp;andnbsp; 9.3.2 Company snapshotandnbsp;andnbsp;andnbsp; 9.3.3 Business performanceandnbsp;andnbsp;andnbsp; 9.3.4 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.3.4.1 Primary strategy: FDA approvalsandnbsp;andnbsp;andnbsp; 9.3.5 SWOT Analysis of Irvine scientificandnbsp;9.4 Cooper Surgical, Inc.andnbsp;andnbsp;andnbsp; 9.4.1 Company overviewandnbsp;andnbsp;andnbsp; 9.4.2 Company snapshotandnbsp;andnbsp;andnbsp; 9.4.3 Business performanceandnbsp;andnbsp;andnbsp; 9.4.4 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.4.4.1 Primary strategiesandnbsp;andnbsp;andnbsp; 9.4.5 SWOT Analysis of Cooper Surgical, Incandnbsp;9.5 Cook Medical, Incandnbsp;andnbsp;andnbsp; 9.5.1 Company overviewandnbsp;andnbsp;andnbsp; 9.5.2 Company snapshotandnbsp;andnbsp;andnbsp; 9.5.3 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.5.3.1 Primary strategiesandnbsp;andnbsp;andnbsp; 9.5.4 SWOT Analysis of Cook medicalandnbsp;9.6 Thermo Fisher Scientific Inc.andnbsp;andnbsp;andnbsp; 9.6.1 Company overview:andnbsp;andnbsp;andnbsp; 9.6.2 Company snapshotandnbsp;andnbsp;andnbsp; 9.6.3 Business Performanceandnbsp;andnbsp;andnbsp; 9.6.4 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.6.4.1 Primary strategy: product launchandnbsp;andnbsp;andnbsp; 9.6.5 SWOT Analysis of Thermo Fisher Scientific Inc.andnbsp;9.7 Genea Biomedxandnbsp;andnbsp;andnbsp; 9.7.1 Company overviewandnbsp;andnbsp;andnbsp; 9.7.2 Company snapshotandnbsp;andnbsp;andnbsp; 9.7.3 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.7.3.1 Primary strategy: product launchandnbsp;andnbsp;andnbsp; 9.7.4 SWOT Analysis of Genea Biomedxandnbsp;9.8 Auxogyn, Incandnbsp;andnbsp;andnbsp; 9.8.1 Company overviewandnbsp;andnbsp;andnbsp; 9.8.2 Company snapshotandnbsp;andnbsp;andnbsp; 9.8.3 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.8.3.1 Primary strategies- Agreement and partnershipandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.8.3.2 Others strategiesandnbsp;andnbsp;andnbsp; 9.8.4 SWOT Analysis of Auxogyn, Incandnbsp;9.9 Oxford Gene Technologyandnbsp;andnbsp;andnbsp; 9.9.1 Company overviewandnbsp;andnbsp;andnbsp; 9.9.2 Company snapshotandnbsp;andnbsp;andnbsp; 9.9.3 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.9.3.1 Primary strategy: product launchandnbsp;andnbsp;andnbsp; 9.9.4 SWOT analysis of oxford gene technologyandnbsp;9.10 Ovascienceandnbsp;andnbsp;andnbsp;andnbsp; 9.10.1 Company overviewandnbsp;andnbsp;andnbsp;andnbsp; 9.10.2 Business Performanceandnbsp;andnbsp;andnbsp;andnbsp; 9.10.3 Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 9.10.3.1 Primary strategyandnbsp;andnbsp;andnbsp;andnbsp; 9.10.4 SWOT analysis of OvascienceLIST OF TABLES:TABLE 1andnbsp; GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 2andnbsp; INSURANCE COVERAGE FOR COUNTRIESTABLE 3andnbsp; GLOBAL IVF MARKET BY INSTRUMENTS TYPES,2012-2020,$MILLIONTABLE 4andnbsp; GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 5andnbsp; GLOBAL IVF INCUBATORS MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 6andnbsp; GLOBAL IVF CRYOSYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 7andnbsp; GLOBAL IVF IMAGING SYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 8andnbsp; GLOBAL IVF CABINETS MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 9andnbsp; GLOBAL IVF OVUM APIRATION PUMP MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 10andnbsp; GLOBAL IVF SPERM SEPERATION SYSTEM MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 11andnbsp; GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 12andnbsp; GLOBAL IVF MICROMANIPULATOR MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 13andnbsp; GLOBAL IVF OTHER INSTRUMENTS MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 14andnbsp; GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES,2012-2020,$MILLIONTABLE 15andnbsp; GLOBAL IVF REAGENTS AND MEDIA MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 16andnbsp; CRYOPRESERVATION MEDIA BY VARIOUS COMPANIESTABLE 17andnbsp; GLOBAL IVF CRYOPRESERVATION MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 18andnbsp; GLOBAL IVF SEMEN PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 19andnbsp; GLOBAL IVF OVUM PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 20andnbsp; EMBRYO CULTURE MEDIA BY VARIOUS COMPANIESTABLE 22andnbsp; GLOBAL IVF EMBRYO CULTURE MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 23andnbsp; GLOBAL IVF MARKET, BY TECHNOLOGY, 2012-2020, $MILLIONTABLE 24andnbsp; GLOBAL IVF TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 25andnbsp; GLOBAL IVF PRE-IMPLANTATION GENETIC DIAGNOSIS MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 26andnbsp; GLOBAL IVF FROZEN EMBRYO REPLACEMENT MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 27andnbsp; GLOBAL IVF INTRA CYTOPLASMIC SPERM INJECTION MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 28andnbsp; GLOBAL IVF OTHER TECHNOLOGY MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 29andnbsp; GLOBAL IVF MARKET BY END USERS,2012-2020,$MILLIONTABLE 30andnbsp; GLOBAL IVF END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 31andnbsp; GLOBAL IVF HOSPITALS MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 32andnbsp; GLOBAL IVF CLINICS MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 33andnbsp; GLOBAL IVF SURGICAL CENTERS MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 34andnbsp; GLOBAL IVF CLINICAL RESEARCH INSTITUTES MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 35andnbsp; GLOBAL IVF BANKS MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 36andnbsp; EUROPEandrsquo;S ACTIVE COUNTRIES FOR IVF TREATMENT, 2010TABLE 37andnbsp; EMEA IVF MARKET, 2012-2020, $MILLIONTABLE 38andnbsp; NORTH AMERICAN IVF MARKET, 2012-2020, $MILLIONTABLE 39andnbsp; ASIA PACIFIC IVF MARKET, 2012-2020, $MILLIONTABLE 40andnbsp; ROW IVF MARKET, 2012-2020, $MILLIONTABLE 41andnbsp; SNAP SHOT OF VITROLIFE ABTABLE 42andnbsp; SNAP SHOT OF EMD SERONO, INCTABLE 43andnbsp; SNAP SHOT OF IRVINE SCIENTIFICTABLE 44andnbsp; SNAP SHOT OF COOPER SURGICAL, INCTABLE 45andnbsp; SNAP SHOT OF COOK MEDICALTABLE 46andnbsp; SNAP SHOT OF THERMO FISHER SCIENTIFIC INCTABLE 47andnbsp; SNAP SHOT OF GENEA BIOMEDXTABLE 48andnbsp; SNAP SHOT OF AUXOGYN, INCTABLE 49andnbsp; SNAP SHOT OF OXFORD GENE TECHNOLOGYTABLE 50andnbsp; SNAP SHOT OF OVASCIENCELIST OF FIGURES:FIG. 1andnbsp; IUI SUCCESS RATES BY AGE UK, 2010FIG. 2andnbsp; HIGH ORDER BIRTH RATES: MEDICALLY ASSISTED VS IVF TECHNIQUEFIG. 3andnbsp; COST OF BASIC IVF TYPE PROCEDURESFIG. 4andnbsp; PERCENTAGE OF LIVE BIRTH USING DONOR EGGS, U.S.A, 2011FIG. 5andnbsp; LIVE BIRTH RATE PER CYCLE USING DONOR SPERM, U.K. 2010FIG. 6andnbsp; EMBRYOS CREATED USING DONOR EGGS, EUROPEFIG. 7andnbsp; ADOPTION RATE BY TYPE OF SURROGACYFIG. 8andnbsp; TOP FACTORS IMPACTING IVF MARKET (2013-2020)FIG. 9andnbsp; TOP WINNING STRATEGIES OF IVF MARKET (2010-2013)FIG. 10andnbsp; PORTERandrsquo;S FIVE FORCE ANALYSIS:FIG. 11andnbsp; VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKETFIG. 12andnbsp; EFFECT OF AGE ON FERTILITYFIG. 13andnbsp; COMPARISON OF THE MEDIAS USED IN EMBRYO CULTUREFIG. 14andnbsp; SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE ,2011,U.S.AFIG. 15andnbsp; PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2011 (USA)FIG. 16andnbsp; LIVE BIRTH RATE PER CYCLE, AFTER FROZEN EMBRYO TRANSFER, 2011(USA)FIG. 17andnbsp; PERCENTAGES OF COUPLES SEEKING ICSI TREATMENT, BY THE REASON THEY SOUGHT TREATMENT, U.S.A ,2011FIG. 18andnbsp; PERCENTAGE OF CYCLES RESULTING IN LIVE BIRTHS (2010) U.KFIG. 19andnbsp; POLICIES PROVIDED BY ASIAN COUNTRIES TO SUPPORT ART TREATMENTFIG. 20andnbsp; SALES PER REGION 2012FIG. 21andnbsp; SWOT ANALYSIS OF VITROLIFE ABFIG. 22andnbsp; SALES BY REGION, 2012FIG. 23andnbsp; SWOT ANALYSIS OF EMD SERONO, INCFIG. 24andnbsp; SWOT ANALYSIS OF IRVINE SCIENTIFICFIG. 25andnbsp; SWOT ANALYSIS OF COOPER SURGICAL, INCFIG. 26andnbsp; SWOT ANALYSIS OF COOK MEDICALFIG. 27andnbsp; FINANCIAL REVENUES BY BUSINESS UNITS (2012)FIG. 28andnbsp; FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)FIG. 29andnbsp; SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC INC.FIG. 30andnbsp; SWOT ANALYSIS OF GENEA BIOMEDXFIG. 31andnbsp; SWOT ANALYSIS OF AUXOGYN, INCFIG. 32andnbsp; SWOT ANALYSIS OF OXFORD GENE TECHNOLOGYFIG. 33andnbsp; SWOT ANALYSIS OF OVASCIENCEandnbsp;

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2016 Competing in the Global Cancer Diagnostics Market

2016 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.